Merck & Co. has posted a seven-year history of its list price increases to its website, Reuters reports, and it shows average price hikes of more than 9 percent for its medicines. The highest increase was 10.5 percent, which is significant because 10 percent is the level that three global drugmakers have set as a voluntary limit for their price hikes. Other drug companies are looking at similar disclosures to become more transparent about their pricing, in part because of pressure from Washington.
Merck discloses seven years of list price increases
